| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.75M | - | |
| Dir | 164.0K | $12.45M | -8,000 | |
| VP | 100.3K | $7.61M | - | |
| VP | 83.3K | $6.32M | -60,846 | |
| CFO | 82.7K | $6.27M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 7,072 | $32.86 | $232,407.14 | -6.8% | -12.2% | +136.5% | |
| Jan 16, 2025 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sale+OE | 4,267 | $32.78 | $139,855.19 | -21.1% | -12.2% | +136.5% | |
| Jan 16, 2025 | Birchler Brian52 | EVP, Corp And Development Ops | Sale+OE | 5,400 | $32.70 | $176,580.00 | -8.9% | -12.2% | +136.5% | |
| Jan 16, 2025 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 6,752 | $32.90 | $222,113.79 | -6.9% | -12.2% | +136.5% | |
| Jan 16, 2025 | Baroldi Joseph52 | EVP, Chief Business Officer | Sale+OE | 4,430 | $32.70 | $144,861.00 | -13.6% | -12.2% | +136.5% | |
| Dec 23, 2024 | Hayden Michael R58 | Director | Buy | 5,000 | $36.22 | $181,078.75 | +7.9% | -7.3% | +122.6% | |
| Nov 12, 2024 | Swayze Eric63 | EVP Research | Sell | 1,194 | $37.92 | $45,277.67 | -3.4% | -16.7% | +92.4% | |
| Nov 12, 2024 | Monia Brett P60 | Chief Executive Officer | Sell | 6,630 | $38.05 | $252,294.04 | -3.8% | -16.7% | +92.4% | |
| Nov 12, 2024 | Loscalzo Joseph | Director | Sell | 13,508 | $37.86 | $511,426.39 | -29.5% | -16.7% | +92.4% | |
| Oct 16, 2024 | Swayze Eric63 | EVP Research | Sale+OE | 53 | $38.31 | $2,030.59 | -25.2% | -16.5% | +86.6% |